MYCN and neuroblastoma: All-trans retinoic acid (ATRA) and isotretinoin (13-cis-retinoic acid = 13-cisRA)-induced morphological differentiation5, decreased MYCN expression, and decreased cell proliferation in both MYCN gene-amplified and non-amplified human neuroblastoma cells in vitro6,7.